Lifeward Shareholders Approve Strategic Oramed Deal to Form Bio-Giant
Lifeward Ltd. shareholders have officially approved a strategic partnership with Oramed Pharmaceuticals, marking the final hurdle for a deal aimed at creating a diversified biomedical entity. The collaboration combines Lifeward’s expertise in wearable robotics with Oramed’s clinical pipeline and capital, signaling a significant shift in corporate strategy for both firms.